ACADIA PHARMACEUTICALS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ACADIA PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 1.05M shares, a 360.92% increase from fiscal 2022.
- ACADIA PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 226.94K shares, a 60.71% decline from fiscal 2021.
- ACADIA PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 577.63K shares, a 77.54% decline from fiscal 2020.
- ACADIA PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 2.57M shares, a 33.73% decline from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2023-12-31 | 1.05M shares 10-K · filed 2024-02-28 | |
| 2022-12-31 | 226.94K shares 10-K · filed 2023-02-28 | |
| 2021-12-31 | 577.63K shares 10-K · filed 2022-03-01 | |
| 2020-12-31 | 2.57M shares 10-K · filed 2021-02-25 | |
| 2019-12-31 | 3.88M shares 10-K · filed 2020-02-27 | |
| 2018-12-31 | 599.53K shares 10-K · filed 2019-02-27 | |
| 2017-12-31 | 1.44M shares 10-K · filed 2018-02-27 | |
| 2016-12-31 | 1.98M shares 10-K · filed 2017-02-28 | |
| 2015-12-31 | 1.82M shares 10-K · filed 2016-02-29 | |
| 2014-12-31 | 1.49M shares 10-K · filed 2015-02-26 | |
| 2013-12-31 | 1.46M shares 10-K · filed 2014-02-27 | |
| 2012-12-31 | 293.60K shares 10-K · filed 2013-03-12 | |
| 2011-12-31 | 10.43K shares 10-K · filed 2013-03-12 | |
| 2010-12-31 | 10.82K shares 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |